Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia. | Best Pract Res Clin Haematol | 2023 | 37353287 | PubTator, text mining | PubMed |
| Community detection in empirical kinase networks identifies new potential members of signalling pathways. | PLoS Comput Biol | 2023 | 37352361 | PubTator, text mining | PubMed |
| Microtubule stabilization targeting regenerative chondrocyte cluster for cartilage regeneration. | Theranostics | 2023 | 37351173 | PubTator, text mining | PubMed |
| Hepatitis C Virus (HCV)-Ribonucleic Acid (RNA) As a Biomarker for Lymphoid Malignancy with HCV Infection. | Cancers (Basel) | 2023 | 37345190 | PubTator, text mining | PubMed |
| RUNX1T1 modulates myogenic differentiation by regulating the calcium signaling pathway and the alternative splicing of ROCK2. | FASEB J | 2023 | 37342905 | PubTator, text mining | PubMed |
| Applications of Boolean modeling to study the dynamics of a complex disease and therapeutics responses. | Front Bioinform | 2023 | 37325771 | PubTator, text mining | PubMed |
| Optic nerve diseases and regeneration: How far are we from the promised land? | Clin Exp Ophthalmol | 2023 | 37317890 | PubTator, text mining | PubMed |
| CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis. | Sci Rep | 2023 | 37316699 | PubTator, text mining | PubMed |
| Neurological update: non-motor symptoms in atypical parkinsonian syndromes. | J Neurol | 2023 | 37316556 | PubTator, text mining | PubMed |
| Contributions of coxsackievirus adenovirus receptor to tumorigenesis. | Biochem Soc Trans | 2023 | 37306404 | PubTator, text mining | PubMed |
| Fasudil may alleviate alcohol-induced astrocyte damage by modifying lipid metabolism, as determined by metabonomics analysis. | PeerJ | 2023 | 37304877 | PubTator, text mining | PubMed |
| S-Palmitoylation during Retinoic Acid-Induced Neuronal Differentiation of SH-SY5Y Neuroblastoma Cells. | J Proteome Res | 2023 | 37294931 | PubTator, text mining | PubMed |
| Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views. | J Transl Med | 2023 | 37291585 | PubTator, text mining | PubMed |
| Identifying promising GSK3β inhibitors for cancer management: a computational pipeline combining virtual screening and molecular dynamics simulations. | Front Chem | 2023 | 37284581 | PubTator, text mining | PubMed |
| Study protocol: Phase I/II trial of induced HLA-G+ regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor. | Front Med (Lausanne) | 2023 | 37275377 | PubTator, text mining | PubMed |
| Epigenetic regulation and therapeutic targets in the tumor microenvironment. | Mol Biomed | 2023 | 37273004 | PubTator, text mining | PubMed |
| Microenvironment commits breast tumor ECs to dedifferentiation by micro-RNA-200-b-3p regulation and extracellular matrix remodeling. | Front Cell Dev Biol | 2023 | 37261072 | PubTator, text mining | PubMed |
| Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma. | Pharmaceuticals (Basel) | 2023 | 37259439 | PubTator, text mining | PubMed |
| Protection of H2S against Hypoxia/Reoxygenation Injury in Rat Hippocampal Neurons through Inhibiting Phosphorylation of ROCK2 at Thr436 and Ser575. | Pharmaceuticals (Basel) | 2023 | 37259366 | PubTator, text mining | PubMed |
| Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal. | Pharmaceuticals (Basel) | 2023 | 37259311 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=23